Going forward, PolyNovo and Beta Cell are in collaboration discussions to accelerate research anddevelopment pathways to ensure PolyNovo’s technology can play a major role in the cell therapy market space which is estimated to be USD $34 Billion by 2034
Wow there must be other applications for this cell therapy besides Type 1 Diabetes.
Ann: BTM delivers positive First in Man results in Cell Therapies, page-236
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.085(6.72%) |
Mkt cap ! $815.1M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.27 | $1.16 | $3.705M | 3.105M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2155 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 3794 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |